Clinical registry metadata as a hidden bottleneck in AI-driven drug discovery: a computational audit of translational phase data in glioma research
Year: 2026
Type: article
Abstract: Clinical translation in glioma and glioblastoma remains inefficient despite advances in computational drug discovery. An underrecognized contributor to this gap is structural degradation of clinical registry metadata. We analyzed the complete set of 2.357 glioma-related clinical trial records available in the WHO ICTRP registry at the time of extraction (3 January 2026). A deterministic Python-based validation pipeline was developed to normalize phase and study-type annotations while distinguishing technical voids, methodological non-applicability, and structurally inconsistent entries. Two quantitative indices were introduced: the Reporting Gap ([Formula: see text]), reflecting phase metadata completeness, and the Maturity Ratio ([Formula: see text]), describing the balance between early and late translational stages. Phase annotation showed substantial structural degradation, with large fractions of records lacking machine-interpretable phase labels, whereas study-type fields demonstrated high completeness but severe terminological fragmentation. This asymmetry indicates a systemic mismatch between real-world research designs and the classical phase ontology. Consequently, clinically relevant evidence remains invisible to algorithms, which may lead to biased AI-based translational evaluation. The results suggest that semantic validation of registry metadata is a critical prerequisite for robust integration of clinical data into computational drug development cycles.
Source: Scientific Reports
Author: Iryna Oliynyk
Language: English
Subfield: Information Systems
Field: Computer Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7165153161